Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sepsis | 19 | 2020 | 165 | 1.900 |
Why?
|
| Inflammation | 18 | 2020 | 536 | 1.440 |
Why?
|
| Sirtuin 1 | 11 | 2020 | 37 | 1.110 |
Why?
|
| Lipopolysaccharides | 11 | 2020 | 115 | 1.060 |
Why?
|
| Transcription Factor RelB | 9 | 2013 | 26 | 0.960 |
Why?
|
| Lung Injury | 8 | 2018 | 67 | 0.920 |
Why?
|
| Immune Tolerance | 7 | 2018 | 70 | 0.900 |
Why?
|
| Energy Metabolism | 7 | 2020 | 155 | 0.830 |
Why?
|
| Contusions | 7 | 2018 | 41 | 0.720 |
Why?
|
| Endotoxins | 9 | 2016 | 37 | 0.690 |
Why?
|
| Leukocytes | 8 | 2017 | 57 | 0.680 |
Why?
|
| Epigenesis, Genetic | 5 | 2011 | 107 | 0.620 |
Why?
|
| Monocytes | 6 | 2020 | 130 | 0.600 |
Why?
|
| Gene Silencing | 6 | 2009 | 45 | 0.560 |
Why?
|
| Promoter Regions, Genetic | 8 | 2011 | 208 | 0.540 |
Why?
|
| Sirtuins | 4 | 2018 | 21 | 0.490 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 475 | 0.480 |
Why?
|
| Sirtuin 2 | 4 | 2019 | 10 | 0.440 |
Why?
|
| Transcription, Genetic | 6 | 2011 | 134 | 0.440 |
Why?
|
| Mice | 20 | 2020 | 2511 | 0.440 |
Why?
|
| Heterochromatin | 3 | 2011 | 12 | 0.440 |
Why?
|
| Lung | 5 | 2018 | 265 | 0.440 |
Why?
|
| Interleukin-1beta | 5 | 2011 | 40 | 0.420 |
Why?
|
| Histones | 7 | 2011 | 53 | 0.410 |
Why?
|
| Animals | 27 | 2020 | 7569 | 0.410 |
Why?
|
| NF-kappa B | 4 | 2013 | 83 | 0.400 |
Why?
|
| Toll-Like Receptor 4 | 6 | 2012 | 43 | 0.390 |
Why?
|
| Immunity, Innate | 5 | 2018 | 76 | 0.390 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2016 | 213 | 0.360 |
Why?
|
| Lung Diseases | 2 | 2009 | 48 | 0.360 |
Why?
|
| Interleukin-1 | 4 | 2006 | 32 | 0.350 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 12 | 0.350 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2009 | 5 | 0.310 |
Why?
|
| Pyruvate Dehydrogenase Complex | 2 | 2020 | 18 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 789 | 0.300 |
Why?
|
| MicroRNAs | 1 | 2011 | 188 | 0.290 |
Why?
|
| Chemokine CXCL1 | 5 | 2012 | 15 | 0.280 |
Why?
|
| Transcription Factor RelA | 7 | 2019 | 22 | 0.270 |
Why?
|
| Disease Models, Animal | 11 | 2020 | 1012 | 0.260 |
Why?
|
| Cysteine | 2 | 2019 | 138 | 0.260 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2007 | 11 | 0.260 |
Why?
|
| Humans | 30 | 2020 | 32806 | 0.250 |
Why?
|
| Cell Line | 9 | 2016 | 433 | 0.210 |
Why?
|
| Glucose | 2 | 2017 | 184 | 0.210 |
Why?
|
| Signal Transduction | 5 | 2018 | 686 | 0.210 |
Why?
|
| Homeostasis | 3 | 2018 | 135 | 0.190 |
Why?
|
| Oxidative Stress | 3 | 2019 | 239 | 0.190 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2017 | 43 | 0.180 |
Why?
|
| RNA, Messenger | 4 | 2016 | 498 | 0.180 |
Why?
|
| I-kappa B Proteins | 3 | 2011 | 11 | 0.180 |
Why?
|
| Interleukin-6 | 4 | 2012 | 240 | 0.180 |
Why?
|
| Histocompatibility Antigens | 3 | 2009 | 10 | 0.170 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2009 | 27 | 0.170 |
Why?
|
| Chemokine CXCL2 | 2 | 2011 | 10 | 0.160 |
Why?
|
| Drug Resistance | 2 | 2011 | 39 | 0.160 |
Why?
|
| Microvessels | 2 | 2017 | 28 | 0.160 |
Why?
|
| Succinates | 1 | 2020 | 6 | 0.160 |
Why?
|
| Membrane Glycoproteins | 3 | 2014 | 98 | 0.160 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 11 | 0.160 |
Why?
|
| Cholecystitis, Acute | 1 | 2019 | 11 | 0.160 |
Why?
|
| Multimedia | 1 | 2019 | 19 | 0.160 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 66 | 0.160 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2019 | 21 | 0.160 |
Why?
|
| Photography | 1 | 2019 | 43 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 72 | 0.150 |
Why?
|
| Male | 14 | 2020 | 19645 | 0.150 |
Why?
|
| Stilbenes | 2 | 2015 | 21 | 0.140 |
Why?
|
| Shock, Septic | 1 | 2018 | 26 | 0.140 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 16 | 0.140 |
Why?
|
| Protein Stability | 3 | 2013 | 26 | 0.140 |
Why?
|
| Cytokines | 4 | 2020 | 247 | 0.140 |
Why?
|
| Antioxidants | 1 | 2018 | 115 | 0.130 |
Why?
|
| Platelet Adhesiveness | 3 | 2015 | 14 | 0.130 |
Why?
|
| Phenotype | 2 | 2014 | 638 | 0.130 |
Why?
|
| Mice, Knockout | 4 | 2017 | 453 | 0.130 |
Why?
|
| Vasculitis | 1 | 2017 | 24 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 69 | 0.130 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 4 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 5 | 0.120 |
Why?
|
| Protein Binding | 3 | 2011 | 200 | 0.120 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 20 | 0.110 |
Why?
|
| Obesity | 4 | 2019 | 1152 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2018 | 59 | 0.110 |
Why?
|
| Immunity | 1 | 2014 | 20 | 0.110 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2014 | 87 | 0.110 |
Why?
|
| Complement Activation | 1 | 2014 | 8 | 0.110 |
Why?
|
| Protein Biosynthesis | 2 | 2011 | 38 | 0.110 |
Why?
|
| Chemokines, CXC | 2 | 2011 | 9 | 0.100 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 41 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2012 | 15 | 0.100 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2013 | 6 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 45 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2018 | 820 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2011 | 226 | 0.100 |
Why?
|
| Mice, Obese | 3 | 2019 | 23 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 302 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 497 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2012 | 99 | 0.090 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2011 | 5 | 0.090 |
Why?
|
| Models, Immunological | 1 | 2011 | 8 | 0.090 |
Why?
|
| Adiponectin | 1 | 2011 | 103 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 95 | 0.090 |
Why?
|
| Curcumin | 1 | 2010 | 7 | 0.080 |
Why?
|
| Nucleosomes | 1 | 2009 | 4 | 0.080 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2008 | 5 | 0.080 |
Why?
|
| Carnitine | 2 | 2020 | 14 | 0.080 |
Why?
|
| Principal Component Analysis | 2 | 2020 | 68 | 0.080 |
Why?
|
| Models, Biological | 3 | 2009 | 392 | 0.080 |
Why?
|
| Peroxidase | 1 | 2009 | 28 | 0.080 |
Why?
|
| Metabolome | 2 | 2020 | 37 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 16 | 0.080 |
Why?
|
| Amino Acids | 2 | 2020 | 46 | 0.080 |
Why?
|
| NAD | 3 | 2016 | 27 | 0.070 |
Why?
|
| Cell Adhesion | 3 | 2017 | 103 | 0.070 |
Why?
|
| HMGB1 Protein | 1 | 2009 | 11 | 0.070 |
Why?
|
| Transfection | 2 | 2016 | 184 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 15 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 1140 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2020 | 287 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2006 | 50 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 102 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2005 | 19 | 0.060 |
Why?
|
| Binding Sites | 1 | 2005 | 129 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 267 | 0.060 |
Why?
|
| E-Selectin | 2 | 2017 | 20 | 0.060 |
Why?
|
| Glycolysis | 2 | 2016 | 20 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 726 | 0.050 |
Why?
|
| Adaptation, Biological | 1 | 2003 | 8 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 152 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 59 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 69 | 0.050 |
Why?
|
| Dealkylation | 1 | 2002 | 2 | 0.050 |
Why?
|
| Half-Life | 1 | 2002 | 22 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 26 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 52 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2002 | 21 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2002 | 39 | 0.050 |
Why?
|
| Chromatin | 1 | 2002 | 26 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 163 | 0.040 |
Why?
|
| Microcirculation | 2 | 2011 | 64 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 2011 | 50 | 0.040 |
Why?
|
| Ketones | 1 | 2020 | 11 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 94 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 43 | 0.040 |
Why?
|
| Feedback | 1 | 2019 | 42 | 0.040 |
Why?
|
| Echocardiography | 1 | 2020 | 182 | 0.040 |
Why?
|
| Nucleotides | 1 | 2019 | 16 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2019 | 17 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 60 | 0.040 |
Why?
|
| RNA Interference | 2 | 2009 | 77 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 308 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 64 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 105 | 0.040 |
Why?
|
| Neutrophils | 2 | 2009 | 110 | 0.030 |
Why?
|
| Adult | 1 | 2011 | 9565 | 0.030 |
Why?
|
| Aged | 1 | 2011 | 10539 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 71 | 0.030 |
Why?
|
| Female | 2 | 2015 | 20266 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2008 | 144 | 0.030 |
Why?
|
| Middle Aged | 1 | 2011 | 12128 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 511 | 0.030 |
Why?
|
| Mitochondria | 1 | 2018 | 206 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 31 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 55 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 77 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 113 | 0.030 |
Why?
|
| Cecum | 1 | 2015 | 10 | 0.030 |
Why?
|
| Ribonucleotide Reductases | 1 | 2015 | 6 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 36 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 163 | 0.030 |
Why?
|
| Macrophages | 1 | 2016 | 194 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 199 | 0.030 |
Why?
|
| Carbazoles | 1 | 2014 | 6 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 2183 | 0.030 |
Why?
|
| Complement C5a | 1 | 2014 | 2 | 0.030 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2014 | 2 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2014 | 40 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 16 | 0.030 |
Why?
|
| Hirudins | 1 | 2014 | 19 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 894 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 85 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 73 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 123 | 0.030 |
Why?
|
| Rats | 2 | 2007 | 1606 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 197 | 0.020 |
Why?
|
| Monocyte-Macrophage Precursor Cells | 1 | 2012 | 3 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2012 | 7 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2012 | 13 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 25 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 33 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 55 | 0.020 |
Why?
|
| Radioimmunodetection | 1 | 2011 | 3 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 69 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 20 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 66 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 26 | 0.020 |
Why?
|
| Video Recording | 1 | 2011 | 60 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 136 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2012 | 176 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2010 | 3 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2010 | 7 | 0.020 |
Why?
|
| P-Selectin | 1 | 2010 | 10 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3439 | 0.020 |
Why?
|
| Response Elements | 1 | 2009 | 17 | 0.020 |
Why?
|
| Lysine | 1 | 2009 | 23 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 49 | 0.020 |
Why?
|
| Methylation | 1 | 2009 | 5 | 0.020 |
Why?
|
| CpG Islands | 1 | 2008 | 45 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 129 | 0.020 |
Why?
|
| DNA | 1 | 2008 | 218 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2006 | 4 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2006 | 5 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 731 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 754 | 0.010 |
Why?
|
| Teichoic Acids | 1 | 2003 | 8 | 0.010 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2003 | 14 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 28 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2003 | 24 | 0.010 |
Why?
|